Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-PRDM11 (228-477) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
PRDM11 |
Gene ID: |
56981 |
Uniprot ID: |
PRD11_HUMAN |
Immunogen Region: |
228-477 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 228-477 of human PRDM11 (NP_001243625.1). |
Immunogen Sequence: |
DYMKRLHSMSQETIHRNLAR GEKRLQREKSEQVLDNPEDL RGPIHLSVLRQGKSPYKRGF DEGDVHPQAKKKKIDLIFKD VLEASLESAKVEAHQLALST SLVIRKVPKYQDDAYSQCAT TMTHGVQNIGQTQGEGDWKV PQGVSKEPGQLEDEEEEPSS FKADSPAEASLASDPHELPT TSFCPNCIRLKKKVRELQAE LDMLKSGKLPEPPVLPPQVL ELPEFSDPAGKLVWMRLLS |
Tissue Specificity | Highly expressed in lung, including bronchial epithelial cells and airway smooth muscle cells, as well as in peripheral blood mononuclear cells. In tonsils, expressed in B-cell types, including naive B-cells, centroblasts, centrocytes and memory B-cells (at protein level). In benign hyperplastic lymph nodes, expressed in germinal center cells in both the dark and light zones, as well as in scattered cells in the mantle zone and the interfollicular area (at protein level). |
Function | May be involved in transcription regulation. |
Protein Name | Pr Domain-Containing Protein 11 |
Cellular Localisation | NucleusCytoplasm |
Alternative Antibody Names | Anti-Pr Domain-Containing Protein 11 antibodyAnti-PRDM11 antibodyAnti-PFM8 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance